Phase II study of neoadjuvant and adjuvant gefitinib (G) with neoadjuvant chemoradiotherapy (CRT) in operable esophageal adenocarcinoma (EAC). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Juergens, Rosalyn
  • Gibson, MK
  • Yang, SC
  • Brock, M
  • Heitmiller, R
  • Tsottles, N
  • Rudek, MA
  • Canto, M
  • Kleinberg, L
  • Forastiere, AA

publication date

  • May 20, 2010